SJ Knox

742 total citations
21 papers, 586 citations indexed

About

SJ Knox is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, SJ Knox has authored 21 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in SJ Knox's work include Radiopharmaceutical Chemistry and Applications (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (4 papers). SJ Knox is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (4 papers). SJ Knox collaborates with scholars based in United States and United Kingdom. SJ Knox's co-authors include Michael L. Goris, Katherine M. Bryan, Ning Su, Paul L. Weiden, Darrell R. Fisher, Gregory P. Adams, David Colcher, Ivan D. Horak, Mark Becker and Kirk Trisler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

SJ Knox

21 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Knox United States 12 387 142 138 134 117 21 586
A A Epenetos United Kingdom 10 256 0.7× 102 0.7× 46 0.3× 147 1.1× 45 0.4× 13 533
Olga Ab United States 11 398 1.0× 577 4.1× 79 0.6× 190 1.4× 42 0.4× 23 776
Diane Amox United States 8 171 0.4× 88 0.6× 75 0.5× 121 0.9× 33 0.3× 9 414
G.L. Buraggi Italy 15 583 1.5× 310 2.2× 113 0.8× 205 1.5× 115 1.0× 43 811
A. Lambiase Italy 17 146 0.4× 613 4.3× 40 0.3× 297 2.2× 181 1.5× 55 899
Patrick H. van Berkel United Kingdom 9 181 0.5× 393 2.8× 113 0.8× 112 0.8× 23 0.2× 35 496
Gregory E. Jones United States 8 350 0.9× 463 3.3× 36 0.3× 188 1.4× 29 0.2× 15 622
Mary Agnes Templeton United States 9 150 0.4× 256 1.8× 19 0.1× 237 1.8× 34 0.3× 17 558
Goldenberg Dm United States 11 487 1.3× 171 1.2× 73 0.5× 179 1.3× 63 0.5× 31 617
Robert T. Maguire United States 11 305 0.8× 149 1.0× 92 0.7× 148 1.1× 458 3.9× 22 793

Countries citing papers authored by SJ Knox

Since Specialization
Citations

This map shows the geographic impact of SJ Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Knox more than expected).

Fields of papers citing papers by SJ Knox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Knox. The network helps show where SJ Knox may publish in the future.

Co-authorship network of co-authors of SJ Knox

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Knox. A scholar is included among the top collaborators of SJ Knox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Knox. SJ Knox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiniker, Susan M., et al.. (2015). A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma. International Journal of Radiation Oncology*Biology*Physics. 93(3). S95–S95. 13 indexed citations
2.
Kaminski, Mark, John Radford, J.P. Leonard, et al.. (2005). Re-treatment with Tositumomab and Iodine I 131 Tositumomab in patients with non-Hodgkin lymphoma who had previously responded to Tositumomab and Iodine I 131 Tositumomab. Journal of Clinical Oncology. 2 indexed citations
3.
Gregory, S. A., John P. Leonard, J. M. Vose, et al.. (2005). Superior outcomes associated with earlier use: Experience with tositumomab and iodine I 131 tositumomab in 1,177 patients (pts) with low-grade, follicular, and transformed non-Hodgkin’s lymphoma (NHL). Journal of Clinical Oncology. 23(16_suppl). 6561–6561. 14 indexed citations
4.
Iversen, Lars, Sean Whittaker, Tim Illidge, et al.. (2004). HuMax-CD4, fully human monoclonal antibody: Phase II trial in cutaneous T cell lymphoma. Journal of Investigative Dermatology. 122(3). 2 indexed citations
5.
6.
Press, Oliver W., JM Vose, John Radford, et al.. (2001). Incidence of myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with Bexxar (TM).. Blood. 98(1). 7 indexed citations
7.
Vose, J. M., Andrew D. Zelenetz, A. Z. S. Rohatiner, et al.. (2000). Iodine I 131 Tositumomab for Patients With Follicular Non-Hodgkin’s Lymphoma (NHL): Overall Clinical Trial Experience by Histology. 13 indexed citations
8.
Knox, SJ, Michael L. Goris, Margaret A. Tempero, et al.. (2000). Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.. PubMed. 6(2). 406–14. 163 indexed citations
9.
Trisler, Kirk, et al.. (1996). Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.. PubMed. 2(8). 1289–97. 110 indexed citations
10.
Knox, SJ. (1995). Overview of studies on experimental radioimmunotherapy.. PubMed. 55(23 Suppl). 5832s–5836s. 33 indexed citations
11.
Wilder, Richard B., Virginia K. Langmuir, Holly L. Mendonca, Michael L. Goris, & SJ Knox. (1993). Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.. PubMed. 53(13). 3022–7. 35 indexed citations
12.
Knox, SJ, et al.. (1992). The effect of unlabelled monoclonal antibody (mAb) on the biodistribution of 131I-anti-idiotype mAb in murine B cell lymphoma. Radiotherapy and Oncology. 24(3). 169–176. 1 indexed citations
13.
Knox, SJ, W.H. Sutherland, & Michael L. Goris. (1991). Determinants of low dose rate effects associated with radioimmunotherapy. International Journal of Radiation Oncology*Biology*Physics. 21. 176–176. 5 indexed citations
14.
Knox, SJ, Ronald Levy, Suzanne Hodgkinson, et al.. (1991). Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Blood. 77(1). 20–30. 58 indexed citations
15.
Knox, SJ, Ronald Levy, Suzanne Hodgkinson, et al.. (1991). Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Blood. 77(1). 20–30. 50 indexed citations
16.
17.
18.
Knox, SJ, M. Shifrine, & L.S. Rosenblatt. (1982). Assessment of the in vitro radiosensitivity of human peripheral blood lymphocytes.. PubMed. 89(3). 575–89. 16 indexed citations
19.
Knox, SJ, H. P. Misra, M. Shifrine, & L.S. Rosenblatt. (1982). Radiation-induced Inhibition of Human Lymphocyte Blastogenesis: The Effect of Superoxide Dismutase and Catalase. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 41(3). 283–294. 4 indexed citations
20.
Knox, SJ, et al.. (1982). Growth of Human T Lymphocyte Colonies From Whole Blood: Culture Requirements and Applications. Journal of Cellular Biochemistry. 18(1). 15–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A A Epenetos Breakdown of academic impact, for papers by Olga Ab Breakdown of academic impact, for papers by Diane Amox Breakdown of academic impact, for papers by G.L. Buraggi Breakdown of academic impact, for papers by A. Lambiase Breakdown of academic impact, for papers by Patrick H. van Berkel Breakdown of academic impact, for papers by Gregory E. Jones Breakdown of academic impact, for papers by Mary Agnes Templeton Breakdown of academic impact, for papers by Goldenberg Dm Breakdown of academic impact, for papers by Robert T. Maguire
Rankless by CCL
2026